🦊/Investors

Debiopharm Innovation FundFull Portfolio

19 tracked investments · listed companies and verified rows first

Meda Systemsmedasystems.comin✓ verified

MedaSystems builds a software platform that automates workflows, collects real-world data, and connects physicians with pharmaceutical manufacturers to manage drugs under pre-approval and expanded-access pathways.

Digital HealthHealthtechMedical DevicesSaaSSilicon Valley, US

Brian Irwin(Chief Executive Officer)inJeffrey Thibeault(Chief Technology Officer)in

Co-investorsNina Capital

Octozioctozi.comin✓ verified

Octozi provides AI-powered automation for clinical data workflows including cleaning, review, reconciliation, reporting, and operations in clinical trials.

AI & Machine LearningEnterprise SoftwareMedical Devices

Amit Patel(Founder)inMatt Purri, PhD(Founder)in

Co-investorsEntrepreneurs Roundtable Accelerator (ERA)Remarkable VenturesSurface Ventures

Stratifaistratifai.comin✓ verified

StratifAI develops AI-driven multimodal biomarkers for precision oncology, using its platform to link routine H&E histology and RNASeq gene expression data to patient outcomes for prognostic and predictive insights.

AI & Machine LearningBiotechHealthtechMedical DevicesBerlin, DE

Daniel Truhn(Co-Founder & Chief Medical Officer)inFiras Khader(Co-Founder & CTO)inJakob Nikolas Kather(Co-Founder & CSO)inOmar El Nahhas(CEO & Co-founder)in

Co-investorsPICUS CAPITALAlvenHeliad AGNeulogy Ventures

Altisaltis.vcJun 2023

Altis provides independent, IC-grade investment diligence and market research on private companies from Seed to Series D+, working outside-in without access to management or data rooms.

AI & Machine LearningData & InfrastructureFintech

Co-investorsPrimary Venture PartnersGalapagos Capital

Altis Labsaltislabs.comin𝕏Jun 2023

Altis Labs provides a web-based platform that applies AI models to medical imaging data to generate reproducible predictions and quantifications for clinical trials.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesToronto, CA

Felix Baldauf-Lenschen(Founder & CEO)inJohn(CTO)

Co-investorsCreative Destruction Lab (CDL)FusionOrbiMedBenchstrength Partners

BC Platformsbcplatforms.comin𝕏Sep 2016

BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine.

AI & Machine LearningBiotechData & InfrastructureHealthtechZurich, CH

Nino da Silva(Executive Officer)inTero Silvola(Executive Officer, Director)inMukhtar Ahmed(Chief Executive Officer)in

BoardHannu Vaajoensuu(Director)Jari Heikkinen(Director)Erich Platzer(Director)

Co-investorsJolt CapitalStartAngels Network

Genialisgenialis.cominMar 2023 · $13M

Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies.

AI & Machine LearningBiotechDigital HealthMedical DevicesBoston, US

Miha Štajdohar(Executive Officer, Director)inRafael Rosengarten(Chief Executive Officer and Co-founder)inLuka Ausec(Executive Officer)inHamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)

BoardIta Lu(Director)in

Co-investorsAngelini VenturesTaiwania CapitalFirst Star VenturesScaleX Venturesredalpine

Iktosiktos.aiinMar 2023

Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.

AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR

Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)

Co-investorsM VenturesOmnes Capital

Medablein𝕏

Debiopharm is a biopharmaceutical company that develops and manufactures drugs to treat cancer and infectious diseases, and invests in digital health startups.

BiotechDigital HealthMedical DevicesSwitzerland, CH

Rolland-Yves Mauvernay

BoardThierry Mauvernay

ModernVivomodernvivo.comin

ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development.

AI & Machine LearningBiotechMedical Devices

Ian Levine(Founder)in

OmicsChartomicschart.comin𝕏

Vedaly provides AI, data analytics, and decision support tools for biopharma companies to integrate insights into scientific and strategic planning.

AI & Machine LearningBiotechData & InfrastructureHealthtechSaaSMartinsried, DE

Tanya Aneichyk(PhD, CEO)in

Co-investorsTechstars

Precision medicineconcr.coin

Concr combines AI-driven computational methods with biological expertise to develop precision oncology tools that improve drug selection and delivery for cancer patients.

AI & Machine LearningBiotechMedical DevicesGlasgow, GB

Matthew Griffiths(Chief Technology Officer & Co-Founder)Uzma Asghar(Advisor, Medical Strategy & Co-Founder)Matt Foster(Non-Executive Director (Australia) & Co-Founder)

Co-investorsAvonmore DevelopmentsCambridge Angels groupDeep Science VenturesOncology Ventures

Raidiumraidium.euin

Raidium builds an AI-native PACS viewer embedding a vision-language foundation model to support radiologists across research and clinical work, including automated tumor measurement and lesion segmentation.

AI & Machine LearningDigital HealthMedical DevicesParis, FR

Paul Herent, M.D., Msc(Founder)inPaul Hérent(Co-Founder and CEO)inPierre Manceron(Co-Founder and CSO)inSebastian Schwarz(COO)inDamien Benard(CFO)in

Co-investorsGalion.exeKurma PartnersNewfund CapitalFounders FutureStartX

Risklickrisklick.chin𝕏

RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines.

AI & Machine LearningHealthtechMedical Devices

BoardMatthias Egger(Professor of Epidemiology)

Stitch Healthstitchhealth.coin

Stitch is a platform for clinical research sites that provides participants with a digital interface for their study visits, appointment reminders, and feedback, while reducing administrative workload for study coordinators.

Digital HealthHealthtechSaaSLondon, GB

Mike Sterling(Founder)in

Co-investorsBoost Capital PartnersForm VenturesOncology VenturesBenchmarkY Combinator

Strategikon Pharmastrategikonpharma.comin

Strategikon Pharma develops Clinical Maestro, a software platform for managing clinical business operations including budgeting, sourcing, contracting, and vendor management, with AI-driven cost benchmarking tools.

AI & Machine LearningBiotechHealthtechSaaSSan Francisco, US

Anca Copaescu(Founder)inMark Di Ianni(Executive Officer, Director, Promoter)Paulo Carvalho(Executive Officer)inMark Weinstein(Executive Officer, Director)in

BoardRob Hess(Director)Vincent Lepreux(Director)in

Co-investorsBand of AngelsHearstLabBascom VenturesDecathlon Capital PartnersGolden SeedsOsage Venture Partners+1 more

Tune Insighttuneinsight.comin

Tune Insight develops privacy-preserving data collaboration software that combines homomorphic encryption, secure multiparty computation, differential privacy, and federated learning, allowing organizations to derive insights without directly sharing or manipulating raw data.

CybersecurityData & InfrastructureDeep TechDigital HealthHealthtechBelgium, BE

Co-investorsInflection.xyz14Peaks CapitalFounderful

Views MLviewsml.comin

ViewsML applies AI to support the development and delivery of precision medicines, including virtual IHC technology for pathology.

AI & Machine LearningBiotechHealthtechMedical Devices

Kenneth To(Chief Executive Officer)inKeith Jalbert(Chief Commercial Officer)Christopher Jackson(Chief Scientific Officer)inGeorge Hennen(Chief Technology Officer)inRafay Azhar(Medical Director)in

Co-investorsSFU VentureLabsSwan Venture FundWittington VenturesWUTIF Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

HopeAI

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.